Feng Zhu

5.7k total citations
122 papers, 4.1k citations indexed

About

Feng Zhu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feng Zhu has authored 122 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 36 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Feng Zhu's work include Cancer-related Molecular Pathways (18 papers), Cell death mechanisms and regulation (16 papers) and FOXO transcription factor regulation (14 papers). Feng Zhu is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), Cell death mechanisms and regulation (16 papers) and FOXO transcription factor regulation (14 papers). Feng Zhu collaborates with scholars based in China, United States and South Korea. Feng Zhu's co-authors include Ann M. Bode, Zigang Dong, Yong‐Yeon Cho, Weiya Ma, Tatyana A. Zykova, Cong Peng, Chengrong Lu, Faqing Tang, Ke Yao and Duo Zheng and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and The Journal of Immunology.

In The Last Decade

Feng Zhu

118 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Zhu China 40 2.6k 781 639 445 372 122 4.1k
Fajun Yang United States 29 2.4k 0.9× 523 0.7× 609 1.0× 586 1.3× 316 0.8× 55 4.5k
Gang Song China 29 2.4k 1.0× 755 1.0× 845 1.3× 287 0.6× 403 1.1× 71 4.0k
Jong‐Wook Park South Korea 37 2.4k 1.0× 740 0.9× 602 0.9× 262 0.6× 679 1.8× 137 4.4k
Kangdong Liu China 33 2.4k 0.9× 1.0k 1.3× 769 1.2× 303 0.7× 401 1.1× 202 3.9k
Brian K. Law United States 40 3.2k 1.2× 1.3k 1.6× 569 0.9× 472 1.1× 310 0.8× 138 5.4k
Aree Moon South Korea 42 2.8k 1.1× 1.4k 1.8× 1.1k 1.7× 341 0.8× 557 1.5× 126 5.5k
Shousong Cao United States 39 2.5k 1.0× 1.3k 1.7× 677 1.1× 285 0.6× 368 1.0× 113 4.7k
Krishna Bhat United States 32 3.3k 1.3× 1.4k 1.8× 818 1.3× 536 1.2× 434 1.2× 71 5.4k
Chen Li China 37 2.6k 1.0× 603 0.8× 941 1.5× 222 0.5× 364 1.0× 214 4.4k
Ramzi M. Mohammad United States 41 2.9k 1.1× 1.2k 1.6× 601 0.9× 534 1.2× 374 1.0× 154 4.8k

Countries citing papers authored by Feng Zhu

Since Specialization
Citations

This map shows the geographic impact of Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhu more than expected).

Fields of papers citing papers by Feng Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhu. The network helps show where Feng Zhu may publish in the future.

Co-authorship network of co-authors of Feng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Zhu. A scholar is included among the top collaborators of Feng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Zhu. Feng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, G. -J., Tiantian Cheng, Xiaorong Wang, et al.. (2025). Chrysanthemum morifolium extract attenuates pathological angiogenesis of age-related macular degeneration via VEGF and Nrf2 pathway modulation. Journal of Ethnopharmacology. 355(Pt B). 120660–120660. 1 indexed citations
2.
Yao, Shuo, Yanmei Zou, Hui Lü, et al.. (2023). KRASG12C mutation‐induced TOPK overexpression contributes to tumour progression in non‐small cell lung cancer. Journal of Cellular and Molecular Medicine. 27(12). 1637–1652. 5 indexed citations
3.
Shi, F., et al.. (2023). TOPK promotes the development of psoriasis and worenine alleviates psoriasiform dermatitis by inhibiting TOPK activity. Journal of the European Academy of Dermatology and Venereology. 38(5). 851–863. 2 indexed citations
4.
Wang, Wei, et al.. (2022). The role of branched chain amino acids metabolic disorders in tumorigenesis and progression. Biomedicine & Pharmacotherapy. 153. 113390–113390. 29 indexed citations
5.
Liu, Lei, Ming Zhou, Jun Zhou, et al.. (2020). Hydrogen sulfide protects against particle‐induced inflammatory response and osteolysis via SIRT1 pathway in prosthesis loosening. The FASEB Journal. 34(3). 3743–3754. 21 indexed citations
6.
Chen, Wei, et al.. (2020). Research Advances in the Molecular Functions and Relevant Diseases of TAOKs, Novel STE20 Kinase Family Members. Current Pharmaceutical Design. 26(26). 3122–3133. 2 indexed citations
7.
Zou, Yanmei, Shuo Yao, Dian Liu, et al.. (2018). MiR-422a weakened breast cancer stem cells properties by targeting PLP2. Cancer Biology & Therapy. 19(5). 436–444. 33 indexed citations
8.
Zykova, Tatyana A., Feng Zhu, Lei Wang, et al.. (2018). Targeting PRPK Function Blocks Colon Cancer Metastasis. Molecular Cancer Therapeutics. 17(5). 1101–1113. 15 indexed citations
9.
Yang, Ge, Yang Fu, Margarita Malakhova, et al.. (2014). Caffeic Acid Directly Targets ERK1/2 to Attenuate Solar UV-Induced Skin Carcinogenesis. Cancer Prevention Research. 7(10). 1056–1066. 47 indexed citations
10.
Li, Wei, Cong Peng, Mee‐Hyun Lee, et al.. (2013). TRAF4 Is a Critical Molecule for Akt Activation in Lung Cancer. Cancer Research. 73(23). 6938–6950. 91 indexed citations
11.
Li, Haitao, Feng Zhu, Yanwen Sun, et al.. (2013). Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2. PLoS ONE. 8(10). e76452–e76452. 4 indexed citations
12.
Xie, Hua, Mee‐Hyun Lee, Feng Zhu, et al.. (2012). Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform. Cancer Research. 73(2). 716–724. 26 indexed citations
13.
Zhu, Feng, Tatyana A. Zykova, Cong Peng, et al.. (2011). Phosphorylation of H2AX at Ser139 and a New Phosphorylation Site Ser16 by RSK2 Decreases H2AX Ubiquitination and Inhibits Cell Transformation. Cancer Research. 71(2). 393–403. 33 indexed citations
14.
Jin, Yanli, Zhongzheng Lu, Qi Chen, et al.. (2010). The Antitumor Activity of Homoharringtonine against Human Mast Cells Harboring the KIT D816V Mutation. Molecular Cancer Therapeutics. 9(1). 211–223. 25 indexed citations
15.
Xu, Yan‐Ming, Feng Zhu, Yong‐Yeon Cho, et al.. (2010). Extracellular Signal-Regulated Kinase 8–Mediated c-Jun Phosphorylation Increases Tumorigenesis of Human Colon Cancer. Cancer Research. 70(8). 3218–3227. 45 indexed citations
16.
Zykova, Tatyana A., Feng Zhu, Jishuai Zhang, et al.. (2010). T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of Prx1 at Ser-32 Prevents UVB-induced Apoptosis in RPMI7951 Melanoma Cells through the Regulation of Prx1 Peroxidase Activity. Journal of Biological Chemistry. 285(38). 29138–29146. 69 indexed citations
17.
Bode, Ann M., Yong‐Yeon Cho, Duo Zheng, et al.. (2009). Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis. Cancer Research. 69(3). 905–913. 74 indexed citations
18.
Cho, Yong‐Yeon, Faqing Tang, Ke Yao, et al.. (2008). Cyclin-Dependent Kinase-3–Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation. Cancer Research. 69(1). 272–281. 54 indexed citations
19.
Zykova, Tatyana A., Feng Zhu, Chengrong Lu, et al.. (2008). TOPK phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells. Cancer Research. 68. 2707–2707. 1 indexed citations
20.
Xu, Yan‐Ming, Lifeng Wang, Lintao Jia, et al.. (2004). A Caspase-6 and Anti-Human Epidermal Growth Factor Receptor-2 (HER2) Antibody Chimeric Molecule Suppresses the Growth of HER2-Overexpressing Tumors. The Journal of Immunology. 173(1). 61–67. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fajun Yang Breakdown of academic impact, for papers by Gang Song Breakdown of academic impact, for papers by Jong‐Wook Park Breakdown of academic impact, for papers by Kangdong Liu Breakdown of academic impact, for papers by Brian K. Law Breakdown of academic impact, for papers by Aree Moon Breakdown of academic impact, for papers by Shousong Cao Breakdown of academic impact, for papers by Krishna Bhat Breakdown of academic impact, for papers by Chen Li Breakdown of academic impact, for papers by Ramzi M. Mohammad
Rankless by CCL
2026